leisure time -WSS

leisure time

author：knowledge 2025-09-06 03:40:47 - browse：33561

Vertex Pharmaceuticals - sunset — Bill Sikes/AP

LONDON — Regulators in the U.K. on Thursday approved a CRISPR-based medicine to treat both sickle cell disease and beta thalassemia, making it the world’s first therapy built on the revolutionary gene-editing technology and ushering in a new era of genetic medicine.

The authorization of the therapy, from Vertex Pharmaceuticals and CRISPR Therapeutics, is itself not a surprise. Clinical trials have shown the one-time treatment enabled many sickle cell patients to live free of debilitating pain crises and relieved thalassemia patients of needing regular blood transfusions, raising hopes that they have been effectively cured. But it also stands as a major achievement, coming just over a decade after the first and seminal lab experiments that showed CRISPR’s potential as a gene-editing tool were published.

In granting conditional approval to the therapy, which will have the brand name Casgevy and is also known as exa-cel, the U.K.’s Medicines and Healthcare products Regulatory Agency jumped ahead of its counterparts in the U.S. and Europe, which are also reviewing the medicine, in greenlighting the globe’s first CRISPR treatment. The MHRA’s authorization is for patients who are at least 12 years old.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： Don't let 'shelved assets' gather dust. Make them into new lifesaving drugs

WSS

Just how powerful is the placebo effect?

Amylyx ALS drug failure raises questions and concerns

Just how do doctors, lawmakers, and the public define abortion?

Study: New antibiotic targets gonorrhea as well as last existing drug

Change Healthcare payments predicted restored March 15

What it’s like to watch children die of measles

knowledge

leisure time

Wikipedia

Dobbs anniversary: the lost opportunity of abortion as health care

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Just how do doctors, lawmakers, and the public define abortion?

Tori Bowie and the unacceptable rates of Black maternal death

In surprise move, FDA calls for advisory committee on Lilly's Alzheimer's drug

ChatGPT in medicine: STAT answers readers' burning questions

NEJM study link tiny plastics in blood vessels to heart problems

Activists slam private health insurers over coverage restrictions

Diversify hospital leadership teams to protect BIPOC patient health

focus

What it’s like to watch children die of measles

Just how powerful is the placebo effect?

In surprise move, FDA calls for advisory committee on Lilly's Alzheimer's drug

Abortion clinic in Cancun will cater to Americans

Sen. Paul opposes bill to ban Chinese biotechs

Study: New antibiotic targets gonorrhea as well as last existing drug

focus

focus

entertainment

leisure time